However, pituitary tumours may represent the first disease manifestation, and considering the possibility of de novo mutations, screening for MEN1 should be considered in patients with childhood-onset pituitary macroadenomas (especially prolactinomas) [66]. The gene discussed is MEN1; the disease is prolactin-producing pituitary gland adenoma.